Carisma Therapeutics, Inc. (CARM)
NASDAQ: CARM · Real-Time Price · USD
0.1906
-0.0091 (-4.56%)
At close: May 30, 2025, 4:00 PM
0.1906
0.00 (-0.03%)
Pre-market: Jun 2, 2025, 8:20 AM EDT

Carisma Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
May '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Market Capitalization
817118---
Market Cap Growth
-85.86%-85.21%----
Enterprise Value
3-727---
Last Close Price
0.190.422.93---
PS Ratio
0.400.897.93---
PB Ratio
--0.634.46---
P/TBV Ratio
--4.46---
EV/Sales Ratio
0.13-1.80---
Debt / Equity Ratio
-0.06-0.090.12-1.150.100.07
Asset Turnover
0.450.330.190.18--
Quick Ratio
0.741.354.932.643.719.12
Current Ratio
1.341.485.062.783.879.34
Return on Equity (ROE)
-----107.08%-
Return on Assets (ROA)
-69.64%-62.68%-68.59%-65.24%-54.30%-
Return on Capital (ROIC)
--1779.60%-317.29%-206.73%-61.99%-
Earnings Yield
-637.37%-345.88%-73.47%---
FCF Yield
-598.44%-343.38%-69.61%---
Buyback Yield / Dilution
-2.71%-23.66%-1475.33%-96.30%-1.95%-
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q